
News|Articles|July 1, 2010
Formulary Digital Edition, July 2010
Hemophilia: Etiology, complications, and current options in management; Rifaximin: A nonabsorbable, broad-spectrum antibiotic for reduction in the risk for recurrence of overt hepatic encephalopathy; Agents in late-stage development for the treatment of female and male cancers
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Biosimilars provide modest cost savings for cancer patients, study finds
5













